Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Beta-endorphin and obesity. Possible pathogenetic implications].

D Giugliano1, F Saccomanno, A Quatraro

  • 1I Facoltà di Medicina, Università degli Studi di Napoli, Cattedra di Diabetologia e Dietoterapia.

Minerva Endocrinologica
|April 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prediction model to assess the risk of egfr loss in patients with type 2 diabetes and preserved kidney function: The amd annals initiative.

Diabetes research and clinical practice·2022
Same author

COVID-19 in people living with diabetes: An international consensus.

Journal of diabetes and its complications·2020
Same author

Triple-layer Mesh Plasty for Re-recurrent Ventral Hernia in a Liver Transplant Patient: A Case Report.

Transplantation proceedings·2019
Same author

Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus.

Diabetes & metabolism·2017
Same author

Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2017
Same author

Welcome to the 9th Annual meeting of the Diabetes & Cardiovascular disease.

Diabetes & metabolism·2016

Obese individuals have higher beta-endorphin levels, which persist even after weight normalization. Formerly obese subjects exhibit similar metabolic responses to beta-endorphin as obese individuals.

Area of Science:

  • Endocrinology
  • Neuroscience
  • Metabolic research

Context:

  • Opiates and opioid peptides stimulate food intake.
  • Obese patients exhibit elevated plasma beta-endorphin levels.
  • These findings suggest potential pathogenetic implications in obesity.

Purpose:

  • Investigate metabolic and hormonal responses to human beta-endorphin infusion.
  • Compare responses in formerly obese individuals (weight-normalized by dieting) and lean controls.
  • Determine if weight normalization corrects elevated beta-endorphin levels in obesity.

Summary:

  • Formerly obese subjects, despite normalized body weight, maintain higher plasma beta-endorphin concentrations compared to lean controls.
  • Infusion of human beta-endorphin elicited similar glucose, insulin, C-peptide, and glucagon responses in formerly obese and obese subjects.

Related Experiment Videos

  • These results indicate that metabolic and hormonal alterations associated with obesity persist even after weight loss.

    • Impact:

    • Provides insight into the persistent neuroendocrine factors contributing to obesity.
    • Suggests that beta-endorphin system dysregulation may play a role in maintaining obesity-related metabolic profiles.
    • Highlights the complexity of obesity beyond simple caloric balance, involving hormonal and neural pathways.